AusMedTech 2011 Draft Program - Ausbiotech National Conference

More documents

Recommendations

Info

7:00pm – 11:00pm AusBiotech - CSL Official Conference Dinner Friday 2 November 8:00am – 5:30pm 8:00am – 2:00pm 8:00am – 5:30pm Australasian Life Sciences & Investment Summit (by invitation only – separate registration required) BioIndustry Exhibition & Business Matching Open AusFoodtech 9:00am – 10:30am Doing Business in India By 2015 the Indian pharmaceutical market is expected to be worth $20B with 10% of this coming from novel therapeutics. This session will provide you with knowledge and experience of doing biotechnology / pharmaceutical business in India. Session sponsored by The Government of Victoria VLSCI Life Sciences Computation Assoc Prof Andrew Lonie, Head of Life Sciences Computation Centre, VLSCI, Melbourne, Australia. Prof Gary Egan, Director of Monash Biomedical Imaging (MB), Monash University, Clayton, Australia Dr Michael Kuiper, Molecular Modelling Scientist, VLSCI, Melbourne, Australia 10:30am – 11:00am Morning Tea and Networking with BioIndustry Exhibitors 8 28/09/2012 Draft Program - subject to change
11:00am – 12:30pm Realising Value: Bridging the Gap Between Science & Commercial Success Chair: Dr Colin White, President, Invetech PART 1: Core Science Market Access: Risk Sharing (Health Technology Assessment, Value Based Pricing) Goes Global- Implications for Australian Biotech Managing Risks in Clinical Trials Chair: George Gilmour, Senior Underwriter Technology Insurance Specialty Concept /idea, science and technologies with commercial potential. Building a business case and lessons learned Chair: Robert Salt, Founder & Principal, SALT Global Consulting LLC Travis McIntosh, Assistant Vice President, Life Science Specialist, Asia Pacific Zone, Chubb Insurance Company of Australia Limited PART 2: Product Development David James, Director – Biomedical Instruments & Devices, Invetech Gary Phillips, Chief Operating Officer, Pharmaxis Lisa Nelson, General Manager & Chief Executive Officer, Nucleus Network PART 3: Route-to-market Leigh Farrell, Vice President Business Development, Biota Holdings Ltd Session sponsored by Invetech Further session details to be confirmed Dr Michelle Miller, Chief Executive Officer & Managing Director, Biotron Limited Session sponsored by Chubb Australia Ltd 12:30pm – 2:00pm Closing Reception 9 28/09/2012 Draft Program - subject to change
Page 1 and 2: Monday 29 October 9:00am - 5:00pm A
Page 3 and 4: 3:30pm - 5:00pm Development of Biop
Page 5 and 6: Plenary Session 5| Presentation tit
Page 7: 3:30pm - 5:00pm Recent Developments

AusMedTech 2011 Draft Program - Ausbiotech National Conference

Create successful ePaper yourself

Delete template?

Save as template?